Sutro Biopharma (STRO) Capital Expenditures Growth (3y) (2020 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Capital Expenditures Growth (3y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 23.48% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 63.07% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -45.93% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | -40.95% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 29.63% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 60.74% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 27.08% |
| 10 | Sutro Biopharma | 334.66 Mn | 170.32 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -62.05% |
| Sep 30, 2025 | -30.20% |
| Jun 30, 2025 | -66.06% |
| Mar 31, 2025 | -8.90% |
| Dec 31, 2024 | -25.05% |
| Sep 30, 2024 | -45.07% |
| Jun 30, 2024 | -48.12% |
| Mar 31, 2024 | -42.74% |
| Dec 31, 2023 | -3.93% |
| Sep 30, 2023 | -52.05% |
| Jun 30, 2023 | -3.16% |
| Mar 31, 2023 | 7.28% |
| Dec 31, 2022 | 18.00% |
| Sep 30, 2022 | 3.43% |
| Jun 30, 2022 | 65.08% |
| Mar 31, 2022 | 77.86% |
| Dec 31, 2021 | 47.04% |
| Sep 30, 2021 | 140.55% |
| Jun 30, 2021 | 431.76% |
| Mar 31, 2021 | 86.89% |